(Q421934)

moclobemide (English)

3 October 2016

chemical formula

C₁₃H₁₇ClN₂O₂

1 reference

moclobemide (English)

19 November 2016

canonical SMILES

C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl

1 reference

moclobemide (English)

https://www.whocc.no/atc_ddd_index/?code=N06AG02

19 November 2016

defined daily dose

0.3 gram

route of administration

oral administration

1 reference

reference URL

World Health Organisation international non-proprietary name

moclobemide (English)

1 reference

moclobemide (English)

significant drug interaction

3 October 2016

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenylephrine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bupropion

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenylephrine

increased systemic arterial blood pressure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hyperpyrexia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

headache disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(−)-selegiline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

muscle stiffness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

palpitation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

headache disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tachypnea

1 reference

A reference set of clinically relevant adverse drug-drug interactions

anxiety

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

intention tremor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

IUPHAR/BPS Guide to PHARMACOLOGY

17 August 2016

1 reference

Australian pregnancy category B3

17 August 2016

pregnancy category

1 reference

imported from Wikimedia project

1 reference

Medical Subject Headings

MeSH descriptor ID

D020912

monoamine oxidase inhibitor

15 March 2018

1 reference

InChI=1S/C13H17ClN2O2/c14-12-3-1-11(2-4-12)13(17)15-5-6-16-7-9-18-10-8-16/h1-4H,5-10H2,(H,15,17)

Medical Subject Headings

15 March 2018

Moclobemide

0 references

Identifiers

InChI

1 reference

moclobemide (English)

19 November 2016

2 references

moclobemide (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

71320-77-9

2 references

Global Substance Registration System

https://commonchemistry.cas.org/detail?cas_rn=71320-77-9

moclobemide (English)

19 November 2016

7 April 2021

1 reference

Moclobemide (English)

19 November 2016

1 reference

moclobemide (English)

19 November 2016

Reaxys registry number

530974

1 reference

moclobemide (English)

3 October 2016

ChEBI ID

83531

mapping relation type

2 references

MOCLOBEMIDE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C13H17ClN2O2/c14-12-3-1-11(2-4-12)13(17)15-5-6-16-7-9-18-10-8-16/h1-4H,5-10H2,(H,15,17)

1 reference

MOCLOBEMIDE (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU227901

1 reference

MassBank accession ID

0 references

MSBNK-Athens_Univ-AU227902

0 references

MSBNK-Athens_Univ-AU227903

0 references

MSBNK-Athens_Univ-AU227904

0 references

MSBNK-Athens_Univ-AU227905

0 references

MSBNK-Athens_Univ-AU227906

0 references

MSBNK-Athens_Univ-AU227957

0 references

MSBNK-Athens_Univ-AU227958

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Waters-WA002051

0 references

MSBNK-Waters-WA002052

0 references

MSBNK-Waters-WA002053

0 references

MSBNK-Waters-WA002054

0 references

MSBNK-Waters-WA002055

0 references

MSBNK-Waters-WA002056

0 references

SPLASH

splash10-014i-0090000000-ebaa843d45c4c64c1d3d

0 references

splash10-00lr-0970000000-ab2fbe8b1feae9ff3141

0 references

splash10-001i-0900000000-e3243f45e1029a4c0e71

0 references

splash10-001i-0900000000-927950435244f3ac04e4

0 references

splash10-000i-0900000000-6fe640038cbc911e2bae

0 references

splash10-000i-0900000000-26e37ce9ba0b814b7409

0 references

splash10-014i-0090000000-07e0ca3dba489a2810ec

0 references

splash10-00lr-0980000000-70103607e1e68c966be9

0 references

splash10-001i-0900000000-ac7d3f04849dde0da3d2

0 references

splash10-001r-0900000000-6634fb6b07312ce02ee6

0 references

splash10-000i-0900000000-c43f4a856e6d225766ef

0 references

splash10-000i-0900000000-1231bd387729155af4ab

0 references

splash10-001i-0900000000-a885de4ee2be84e3748d

0 references

splash10-00lr-0950000000-2942178c074461702181

0 references

splash10-0udi-2900000000-c3230d46878446405991

0 references

HSDB ID

7180

1 reference

Hazardous Substances Data Bank

28 October 2019

MOCLOBEMIDE (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.163.935

27 December 2018

ECHA Substance Infocard ID

4-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide (English)

quotation

CAS no.: 71320-77-9 (English)

100.163.935

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.163.935

27 December 2018

4-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide (English)

quotation

CAS no.: 71320-77-9 (English)

1 reference

Moclobemide (English)

publication date

17 November 2015

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

moclobemide (English)

19 November 2016

Moclobemide

1 reference

D02.455.426.559.389.127.085.600

Medical Subject Headings

14 March 2018

0 references

D02.241.223.100.100.600

0 references

D02.241.223.100.200.875

0 references

0 references

D02.455.426.559.389.127.250.875

0 references

RxNorm ID

30121

1 reference

Global Substance Registration System

moclobemide (English)

19 November 2016

DrugBank ID

DB01171

1 reference

Human Metabolome Database ID

HMDB0015302

2 references

based on heuristic

inferred from InChIKey

2 references

Global Substance Registration System

moclobemide (English)

19 November 2016

PatientsLikeMe treatment ID

0 references

0 references

1 reference

1 reference